The Latest in Immunotherapy

Oncology Practice

Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression

November 10, 2019

Oncology Practice

Levothyroxine dose for checkpoint inhibitor toxicity may be too high

November 4, 2019

Hematology News

Behind the scenes of a radical new cancer cure

October 29, 2019

Immunotherapy

Oncology Practice

Inflammatory arthritis induced by ICIs can persist after therapy

October 1, 2019

Immunotherapy

Hematology News

Immunotherapies under investigation in newly diagnosed B-ALL

October 1, 2019

Oncology Practice

Adding radiation to immunotherapy may extend PFS in progressive lung cancer

September 23, 2019

Hematology News

CAR T-cell therapy found safe, effective for HIV-associated lymphoma

September 20, 2019

Oncology Practice

Nivolumab falls short in ccRCC patients with brain metastases

August 28, 2019

Oncology Practice

Pretreatment CT data may help predict immunotherapy benefit in ovarian cancer

August 26, 2019

Oncology Practice

Lichenoid dermatitis with mycosis fungoides features linked to checkpoint inhibitor therapy

July 28, 2019

Oncology Practice

Bullous disorders linked to frequent interruption of immune checkpoint inhibitor treatment

June 26, 2019

Immunotherapy

Oncology Practice

Novel immune checkpoint holds ‘great promise’ as melanoma treatment target

June 25, 2019

Hematology News

Bispecific CAR T-cell therapy yields complete responses in relapsed/refractory non-Hodgkin lymphomas

June 21, 2019

Oncology Practice

Checkpoint inhibitor–induced rheumatic complications have unique features

June 19, 2019

Oncology Practice

Skin plus GI adverse events with checkpoint inhibitors linked to risk of additional adverse events

June 14, 2019